AR-67

N/A

Report date: 2022/11/25 16:34:12
NME

Base Information

Drug NameAR-67
Drug Alias NameSilatecanD-67AR-7AR-67DB-67 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesGliosarcoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArno Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of KentuckyArno Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursMyelodysplastic SyndromesGliosarcoma +[5] 

Other Information

ATC CodeN/A
Related LinksN/A